Contents:

Executive Summary Introduction Asia Central and Eastern Europe Latin America The Emerging Market Outlook Chapter 1 Introduction Introduction Report structure Data caveats The growth of emerging pharmaceutical markets Macroeconomic comparison of regions Asia Central and Eastern Europe Latin America Key trends and conclusions Chapter 2 Asia Summary Introduction Population profile Therapy area analysis Healthcare spend Infrastructure Licensing trends Regional analysis of Asia China Licensing status Prescription dynamics Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Sales and marketing India Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Indonesia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Sales and marketing Malaysia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Intellectual Property legislation Philippines Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Republic Of Korea Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property and clinical trial legislation Singapore Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Thailand Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Sales & marketing Political & economic stability - Asia Chapter 3 Central and Eastern Europe Summary Introduction Population profile Disease burden Therapy area analysis Healthcare spend Infrastructure Licensing trends Business challenges within emergent Europe Regional analysis of Europe Czech Republic Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Hungary Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Poland Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Romania Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Russia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Importation legislation Sales and marketing Prescription dynamics Slovakia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Prescription dynamics Intellectual Property legislation Slovenia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Prescription dynamics Intellectual Property legislation Turkey Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Ukraine Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Sales and marketing Political and economic stability – Central and Eastern Europe Chapter 4 Latin America Summary Introduction Population profile Therapy area analysis Healthcare spend Licensing trends Regional analysis of Latin America Argentina Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Intellectual Property legislation Sales and marketing Brazil Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Chile Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing & reimbursement policies Intellectual Property legislation Colombia Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Mexico Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Prescription dynamics Intellectual Property legislation Peru Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Venezuela Licensing status Therapy area analysis Leading players Financing healthcare Regulatory environment Pricing and reimbursement policies Intellectual Property legislation Political and economic stability – Latin America Chapter 5 The Emerging Market Outlook Introduction Licensing status sales The emerging opportunities Key trends and conclusions Glossary Index

Countries Covered

Asia - China - Indonesia - Malaysia - Philippines - Korea - Singapore - Thailand Central and Eastern Europe - Czech Republic - Hungary - Poland - Romania - Russia - Slovakia - Slovenia - Turkey Latin America - Argentina - Brazil - Chile - Colombia - Mexico - Peru - Venezuela